HIV Preexposure Prophylaxis Cascades to Assess Implementation in Australia: Results From Repeated, National Behavioral Surveillance of Gay and Bisexual Men, 2014-2018.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 03 2020
Historique:
pubmed: 9 1 2020
medline: 15 9 2020
entrez: 9 1 2020
Statut: ppublish

Résumé

HIV prevention cascades can assist in monitoring the implementation of prevention methods like preexposure prophylaxis (PrEP). We developed 2 PrEP cascades for Australia's primary HIV-affected population, gay and bisexual men. Data were drawn from 2 national, repeated, cross-sectional surveys (the Gay Community Periodic Surveys and PrEPARE Project). One cascade had 3 steps, and the other had 7 steps. Trends over time were assessed using logistic regression. For the most recent year, we identified the biggest drop between steps in each cascade and compared the characteristics of men between the 2 steps using multivariate logistic regression. Thirty-nine thousand six hundred and seventy non-HIV-positive men participated in the Periodic Surveys during 2014-2018. PrEP eligibility increased from 28.1% (1901/6762) in 2014 to 37.3% (2935/7878) in 2018 (P < 0.001), awareness increased from 29.6% (563/1901) to 87.1% (2555/2935; P < 0.001), and PrEP use increased from 3.7% (21/563) to 45.2% (1155/2555; P < 0.001). Of 1038 non-HIV-positive men in the PrEPARE Project in 2017, 54.2% (n = 563) were eligible for PrEP, 97.2% (547/563) were aware, 67.6% (370/547) were willing to use PrEP, 73.5% (272/370) had discussed PrEP with a doctor, 78.3% (213/272) were using PrEP, 97.2% (207/213) had recently tested, and 75.8% (157/207) reported reduced HIV concern and increased pleasure because of PrEP. The break point analyses indicated that PrEP coverage was affected by geographical availability, education level, employment, and willingness to use PrEP. PrEP eligibility, awareness, and use have rapidly increased among Australian gay and bisexual men. The cascades identify disparities in uptake by eligible men as a result of socioeconomic factors and PrEP's acceptability.

Sections du résumé

BACKGROUND
HIV prevention cascades can assist in monitoring the implementation of prevention methods like preexposure prophylaxis (PrEP). We developed 2 PrEP cascades for Australia's primary HIV-affected population, gay and bisexual men.
METHODS
Data were drawn from 2 national, repeated, cross-sectional surveys (the Gay Community Periodic Surveys and PrEPARE Project). One cascade had 3 steps, and the other had 7 steps. Trends over time were assessed using logistic regression. For the most recent year, we identified the biggest drop between steps in each cascade and compared the characteristics of men between the 2 steps using multivariate logistic regression.
RESULTS
Thirty-nine thousand six hundred and seventy non-HIV-positive men participated in the Periodic Surveys during 2014-2018. PrEP eligibility increased from 28.1% (1901/6762) in 2014 to 37.3% (2935/7878) in 2018 (P < 0.001), awareness increased from 29.6% (563/1901) to 87.1% (2555/2935; P < 0.001), and PrEP use increased from 3.7% (21/563) to 45.2% (1155/2555; P < 0.001). Of 1038 non-HIV-positive men in the PrEPARE Project in 2017, 54.2% (n = 563) were eligible for PrEP, 97.2% (547/563) were aware, 67.6% (370/547) were willing to use PrEP, 73.5% (272/370) had discussed PrEP with a doctor, 78.3% (213/272) were using PrEP, 97.2% (207/213) had recently tested, and 75.8% (157/207) reported reduced HIV concern and increased pleasure because of PrEP. The break point analyses indicated that PrEP coverage was affected by geographical availability, education level, employment, and willingness to use PrEP.
CONCLUSIONS
PrEP eligibility, awareness, and use have rapidly increased among Australian gay and bisexual men. The cascades identify disparities in uptake by eligible men as a result of socioeconomic factors and PrEP's acceptability.

Identifiants

pubmed: 31913993
doi: 10.1097/QAI.0000000000002243
pii: 00126334-202003010-00006
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16-e22

Références

Medland NA, McMahon JH, Chow EP, et al. The HIV care cascade: a systematic review of data sources, methodology and comparability. J Int AIDS Soc. 2015;18:20634.
Garnett GP, Hallett TB, Takaruza A, et al. Providing a conceptual framework for HIV prevention cascades and assessing feasibility of empirical measurement with data from east Zimbabwe: a case study. Lancet HIV. 2016;3:e297–e306.
Hargreaves JR, Delany-Moretlwe S, Hallett TB, et al. The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring. Lancet HIV. 2016;3:e318–e322.
Schaefer R, Gregson S, Fearon E, et al. HIV prevention cascades: a unifying framework to replicate the successes of treatment cascades. Lancet HIV 2019;6:e60–e66.
van Griensven F, Guadamuz TE, de Lind van Wijngaarden JW, et al. Challenges and emerging opportunities for the HIV prevention, treatment and care cascade in men who have sex with men in Asia Pacific. Sex Transm Infect. 2017;93:356–362.
UNAIDS. Miles to Go: Global AIDS Update 2018. Geneva, Switzerland: UNAIDS; 2018.
Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61:1590–1597.
Parsons JT, Rendina HJ, Lassiter JM, et al. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States. J Acquir Immune Defic Syndr. 2017;74:285–292.
Wilton J, Kain T, Fowler S, et al. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. J Int AIDS Soc. 2016;19:20777.
Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017;31:731–734.
Grulich AE, Guy R, Amin J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5:E629–E637.
Holt M, Lea T, Bear B, et al. Trends in attitudes to and the use of HIV pre-exposure prophylaxis by Australian gay and bisexual men, 2011–2017: implications for further implementation from a Diffusion of Innovations perspective. AIDS Behav. 2019;23:1939–1950.
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for Second Generation HIV Surveillance: The Next Decade. Geneva, Switzerland: World Health Organization and Joint United Nations Programme on HIV/AIDS; 2000.
Paquette D, De Wit J. Sampling methods used in developed countries for behavioural surveillance among men who have sex with men. AIDS Behav. 2010;14:1252–1264.
Ryan KE, Mak A, Stoove M, et al. Protocol for an HIV pre-exposure prophylaxis (PrEP) population level intervention study in Victoria Australia: the PrEPX study. Front Public Health 2018;6:151.
Newman C, Hughes S, Persson A, et al. Promoting equitable access to PrEP in Australia: taking account of stakeholder perspectives. AIDS Behav. 23:1846–1857, 2018.
Levi J, Raymond A, Pozniak A, et al. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob Health. 2016;1:e000010.
Holt M, Lea T, Mao L, et al. Adapting behavioural surveillance to antiretroviral-based HIV prevention: reviewing and anticipating trends in the Australian Gay Community Periodic Surveys. Sex Health. 2017;14:72–79.
The Kirby Institute. HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2018. Sydney, Australia: The Kirby Institute, UNSW Sydney; 2018.
Wright E, Grulich A, Roy K, et al. Australasian society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. J Virus Erad 2017;3:168–184.
Holt M, Murphy DA, Callander D, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88:258–263.
Hammoud MA, Vaccher S, Jin F, et al. HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia and factors associated with the non-use of PrEP among eligible men: results from a prospective cohort study. J Acquir Immune Defic Syndr. 2019;81:e73–e84.
Traeger MW, Schroeder SE, Wright EJ, et al. Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018;67:676–686.
Peng P, Su S, Fairley CK, et al. A global estimate of the acceptability of pre-exposure prophylaxis for HIV among men who have sex with men: a systematic review and meta-analysis. AIDS Behav. 2018;22:1063–1074.
Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11:166–170.
Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV? A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195–216.
Lazarus JV, Safreed-Harmon K, Barton SE, et al. Beyond viral suppression of HIV—the new quality of life frontier. BMC Med. 2016;14:94.
Grulich AE, de Visser RO, Badcock PB, et al. Homosexual experience and recent homosexual encounters: the second Australian study of health and relationships. Sex Health 2014;11:439–450.
Godfrey-Faussett P. The HIV prevention cascade: more smoke than thunder? Lancet HIV 2016;3:e286–e288.
Newman PA, Guta A, Lacombe-Duncan A, et al. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada. J Int AIDS Soc. 2018;21:e25211.

Auteurs

Martin Holt (M)

Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.

Evelyn Lee (E)

Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
Centre for Economic Impacts of Genomic Medicine, Macquarie University, New South Wales, Sydney, Australia.

Toby Lea (T)

Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
German Institute on Addiction and Prevention Research, Catholic University of Applied Sciences, Cologne, Germany.

Benjamin Bavinton (B)

The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Tim Broady (T)

Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.

Limin Mao (L)

Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.

James MacGibbon (J)

Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.

Phillip Keen (P)

The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Dean Murphy (D)

The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Department of Gender and Cultural Studies, the University of Sydney, Sydney, New South Wales, Australia.

Brandon Bear (B)

ACON, Sydney, New South Wales, Australia.

David Crawford (D)

Positive Life NSW, Sydney, New South Wales, Australia.

Jeanne Ellard (J)

Australian Federation of AIDS Organisations, Sydney, New South Wales, Australia.

Johann Kolstee (J)

The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Cherie Power (C)

New South Wales Ministry of Health, Sydney, New South Wales, Australia; and.

Garrett Prestage (G)

The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Andrew Grulich (A)

The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Rebecca Guy (R)

The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

John de Wit (J)

Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
Department of Interdisciplinary Social Science, Utrecht University, Utrecht, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH